Prior Authorization for Medications
ESI Prior Authorization Process:
Prior authorization requests for covered outpatient medications are processed through Express Scripts, Inc. (ESI). ESI is the pharmacy benefits manager for Maryland Physicians Care. Providers can access the Formulary Search Tool to find additional information about medications or call ESI directly at 1-800-753-2851. To find the appropriate Prior Auth form, look below under Prior-Authorization Forms for Outpatient Pharmacy Medications Processed Through ESI.
MPC Medical Benefit Drug Prior Authorization Request Process (Buy & Bill)
Prior authorization for medications reviewed by Maryland Physicians Care must be submitted using the
Medical Benefit Drug Prior Authorization Form.
For MPC Clinical Policies click here
- Actemra IV RX-PA-048
- Acute Hereditary Angioedema Products RX-PA-001
- Adakveo RX-PA-003
- Alpha1-Proteinase Inhibitors RX-PA-004
- Altuviiio RX-PA-086
- Apretude (cabotegravir) RX-PA-058
- Benlysta IV (belimumab) RX-PA-050
- Botox, Dysport, Myobloc, Xeomin RX-PA-005
- Briumvi RX-PA-080
- Cabenuva RX-PA-006
- Cinryze, Haegarda RX-PA-007
- Crysvita RX-PA-060
- Cubicin RX-PA-045
- Dalvance RX-PA-043
- Empaveli RX-PA-039
- Enjaymo RX-PA-075
- Entyvio (vedolizumab) RX-PA-008
- ESA Products RX-PA-065
- Exondys 51 and Vyondys 53 RX-PA-009
- Gattex (Teduglutide) RX-PA-010
- Givlaari RX-PA-091
- Glucocerebrosidase Replacement Enzymes (Ceremyze and VPRIV) RX-PA-011
- GnRH Agonists & Antagonists RX-PA-012
- Granulocyte Colony-Stimulating Factors RX-PA-013
- Hemgenix RX-PA-083
- High Cost Low Volume Drug Risk Mitigation Policy RX-PA-014
- Hyaluronic Acid Derivatives RX-PA-015
- Infliximab Products RX-PA-016
- Intravenous Immune Globulin (IVIG) & Subcutaneous Immune Globulin (SCIG) RX-PA-017
- IV and Injectable Iron Products RX-PA-044
- Juxtapid and Evkeeza RX-PA-040
- Kanuma (sebelipase alfa) RX-PA-019
- Korsuva RX-PA-074
- Kyrstexxa (Pegloticase) RX-PA-020
- Lamzede® RX-PA-088
- Lemtrada (alemtuzumab) RX-PA-047
- Leqembi RX-PA-081
- Leqvio RX.PA.068
- Luxturna RX-PA-089
- Mucopolysaccharidosis Agents RX-PA-021
- Nplate (Romiplostim) RX-PA-023
- Nulibry® (fosdenopterin) RX-PA-041
- Nulojix (Belatacept) RX-PA-024
- Nuzyra for Injection RX-PA-061
- Ocrevus RX-PA-025
- Ocular Disorders RX-PA-026
- Ocular Implants RX-PA-018
- Onpattro RX-PA-027
- Orencia IV RX-PA-052
- Osteoporosis Injectables RX-PA-028
- Oxlumo® (lumasiran) RX-PA-042
- Prevymis IV RX-PA-069
- Pulmonary Arterial Hypertension (PAH) Products RX-PA-029
- Rethymic RX-PA-063
- Revcovi RX-PA-002
- Rituxan (rituximab) RX-PA-030
- Roctavian RX-PA-084
- Ryplazim RX-PA-067
- Saphnelo RX-PA-072
- Signifor (Pasireotide) RX-PA-031
- Simponi Aria RX-PA-073
- Skysona RX-PA-090
- Soliris (Eculizumab) RX-PA-032
- Specialty Drug Management RX-PA-033
- Specialty Enzymes RX-PA-034
- Spinraza RX-PA-035
- Sunlenca RX-PA-082
- Tepezza RX-PA-064
- Tysabri (natalizumab) RX-PA-036
- Ultomiris RX-PA-054
- Vyepti RX-PA-046
- Vyjuvek RX-PA-087
- Xenpozyme RX-PA-085
- Xiaflex (Collagenase Clostridium Histolyticum) MP-097
- Zolgensma RX-PA-038
Non-Formulary Exception Process
To support routine non-Formulary pharmacy authorization decisions, MPC uses guidelines based on FDA-approved indications, evidence-based clinical literature, recognized off-label use supported by peer-reviewed clinical studies, and member’s benefit design, which are applied based on individual members.
The Non-Formulary Guideline is used to evaluate authorization requests for which there are no specific guidelines. A request may be authorized if the medications are deemed to be medically necessary for any of the following reasons:
- up to two (2) formulary drugs (when available) in the same therapeutic category have been utilized for an adequate trial and have not been effective,
- formulary drugs in the same therapeutic category are contra-indicated, or
- there is no therapeutic alternative listed on the Formulary.
To request a non-formulary exception, call the prior authorization team at Express Scripts, Inc. at 1-800-753-2851.
Specialty Medications
Prior authorization review for specialty medications is based on the pharmacy benefit used for the distribution of the medication.
Oncology Medications
Eviti will process prior Authorization for medications related to an oncology treatment regimen. Your office can sign up for training at https://connect.eviti.com to learn how to access the web-based system. If you have any additional questions, please call Eviti, Inc., our oncology vendor, at 1-888-678-0990 (toll-free).
Request for authorization for oncology medications off-label use will be processed through Maryland Physicians Care.
Hepatitis C Medications
Hepatitis C drug prior authorizations are processed by MPC’s Pharmacy Department using the Maryland Department of Health (MDH) Hepatitis C clinical criteria. Fax the completed MDH Hepatitis C Prior Authorization Form with clinical information to 800-953-8856.
Prior Authorization Forms for Outpatient Pharmacy Medications Processed Through ESI
- Ampyra (dalfampridine)
- Anticoagulants Oral Non-Formulary
- Antimalarial Agents
- ARBs
- Avonex (interferon beta-1a)
- Benznidazole
- Betaseron (interferon beta-1a)
- Boniva IV (ibandronate)
- Cayston (aztreonam)
- CCR5 Antagonists
- Celebrex (celecoxib)
- Cialis (tadalafil)
- Cinqair (reslizumab)
- Combination Regimen (HIV)
- Crestor (rosuvastatin)
- Crysvita (burosumab-twza)
- Cubicin (daptomycin)
- Cystagon (cysteamine)
- Daliresp (roflumilast)
- Daraprim (pyrimethamine)
- Direct Renin Inhibitors
- Doptelet (avatrombopag)
- DPP4 Inhibitors
- Duavee (bazedoxifene-conjugated estrogens)
- Dupixent (dupilumab)
- Egrifta (tesamorelin)
- Eliquis (apixaban)
- Emflaza (deflazacort)
- Entresto (sacubitril-valsartan)
- Esbriet (pirfenidone)
- Extavia (interferon beta-1a)
- Glatopa (Glatiramer)
- Global PA Criteria
- Global Quantity Limit Criteria
- GLP-1 Agonists
- Hetlioz (tasimelteon)
- Hyperlipidemia Medications
- Idiopathic Pulmonary Fibrosis Agents
- Ilumya (tildrakizumab-asmn)
- Insulin Pens (Admelog, Humalog, Novolog)
- Integrase Inhibitors
- Intravaginal Progesterone Products
- Intuniv (guanfacine) and Kapvay (clonidine)
- Invokana (canagliflozin)
- Isotretinoin Agents
- Kalydeco (ivacaftor)
- Keveyis (dichlorphenamide)
- Korlym (mifepristone)
- Kuvan (sapropterin)
- Lidoderm (lidocaine)
- Makena (hydroxyprogesterone)
- Movantik (naloxegol)
- Nasal Steroids
- Natroba (spinosad)
- Nityr (nitisone)
- Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
- Nucleoside & Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
- Nuzyra
- Ocaliva (obeticholic acid)
- Ofev (nintedanib)
- Olumiant (baricitinib)
- Onychomycosis Agents
- Opioid Universal PA Form
- Orenitram (treprostinil)
- Orfadin (nitisone)
- Palynziq (pegvaliase)
- Pegasys (peginterferon alfa-2a)
- Platelet Inhibitors
- Praluent (alirocumab)
- Promacta (eltrombopag)
- Protease Inhibitors
- Pulmonary Hypertension Agents (Adcirca, Adempas, Letairis, Opsumit, Tracleer)
- Pulmozyme (dornase alfa)
- Ranexa (ranolazine)
- Remodulin (treprostinil)
- Repatha (evolocumab)
- Restasis & Xiidra
- Revatio (sildenafil)
- Savella (milnacipran)
- Somavert (pegvisomant)
- Symdeko (tezacaftor-ivacaftor)
- Symlin (pramlintide)
- Tavalisse (fostamatinib)
- Tecfidera (dimethyl fumerate)
- Testosterone Agents
- Topical Hyaluronic Acid Agents
- Topical NSAIDs for Arthritis and Pain
- Tymlos (abaloparatide)
- Tyvaso (treprostinil)
- Uloric (febuxostat)
- Uptravi (selexipag)
- Vancocin (vancomycin)
- Veletri (epoprostenol)
- Ventavis (iloprost)
MPC/Eviti Pharmacy Prior Authorization Search Tool
Using our look-up tool, providers easily find if medications require authorization.
Medications requiring MPC Prior Authorization use the Medical Benefit Drug Prior Auth Form.
Name | Formulary Status | Eviti PA | MPC PA | 90 Day |
---|